Hlib Chabaniuk

Teladoc Health, Inc. urges shift in care management as GLP-1 drugs reveal gaps in outcomes

Teladoc Health, Inc. urges shift in care management as GLP-1 drugs reveal gaps in outcomes
Teladoc urges new care models

Teladoc Health, Inc. reports that increased access alone is not improving patient outcomes, with specialty drugs such as GLP-1s bringing significant shortcomings in current care strategies to light.

The company engaged Chris Regal from AHIP to analyze the trends driving health plans to reconsider how care is managed rather than simply covered. Their discussion highlights that insurers are adapting their approach to better address the complexities introduced by advanced therapies in the market.

Teladoc Health has previously expanded its virtual care offerings through a partnership with Mercer at Davids Bridal, delivering measurable cardiometabolic improvements for employees. The company also worked with a global retailer to launch integrated care for diabetes and weight management. Both initiatives focused on managing chronic conditions with virtual support.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.